These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 6091156)

  • 1. [Drug permeation through artificial lipid membranes. 17. The mechanism of ion pair transport].
    Neubert R; Fürst W; Böhm W; Dabow S
    Pharmazie; 1984 Jun; 39(6):401-3. PubMed ID: 6091156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug permeation through synthetic lipid membranes. Part 13: The effects of tensides on the permeation of ionized drugs (author's transl)].
    Fürst W; Neubert R; Förster B; Reppel L
    Pharmazie; 1980; 34(5-6):315-6. PubMed ID: 7413708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug transport through artificial lipoid membranes. 21. Ion pair transport with alkyl salicylic acids].
    Neubert R; Fürst W; Schleiermacher H; Bergmann P; Stolte E
    Pharmazie; 1987 May; 42(5):309-11. PubMed ID: 3671439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quasi-equilibrium analysis of the ion-pair mediated membrane transport of low-permeability drugs.
    Miller JM; Dahan A; Gupta D; Varghese S; Amidon GL
    J Control Release; 2009 Jul; 137(1):31-7. PubMed ID: 19264104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug permeation through synthetic lipoid membranes. 18. The mechanism of ion-pair permeation proton countertransport].
    Neubert R; Fürst W; Schleiermacher H
    Pharmazie; 1985 Jun; 40(6):426-7. PubMed ID: 4034654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug permeation through artificial lipoid membranes. 2. Mathematical description of substance transport].
    Falk M; Fürst W
    Pharmazie; 1973; 28(11):765-8. PubMed ID: 4791265
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of the action of tenside on permeation through lipid membranes].
    Falk M
    Pharmazie; 1988 Apr; 43(4):256-8. PubMed ID: 3413213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SC lipid model membranes designed for studying impact of ceramide species on drug diffusion and permeation--part II: diffusion and permeation of model drugs.
    Ochalek M; Podhaisky H; Ruettinger HH; Wohlrab J; Neubert RH
    Eur J Pharm Biopharm; 2012 Oct; 82(2):360-6. PubMed ID: 22750439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug permeation through synthetic lipid membranes. 11. Various membrane types used in permeation and absorption models].
    Fürst W; Neubert R; Richter H; Reppel L
    Pharmazie; 1980 Feb; 35(2):120-1. PubMed ID: 7384181
    [No Abstract]   [Full Text] [Related]  

  • 10. Permeation characteristics of a hydrophilic basic compound across a bio-mimetic artificial membrane.
    Sugano K; Nabuchi Y; Machida M; Asoh Y
    Int J Pharm; 2004 May; 275(1-2):271-8. PubMed ID: 15081157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced in vitro skin permeation of cationic drugs.
    Green PG; Hadgraft J; Ridout G
    Pharm Res; 1989 Jul; 6(7):628-32. PubMed ID: 2798314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug permeability through artificial lipid membranes. 15: Effect of anions on the transport of buformin in model membranes and isolated, lumen- and vessel-perfused small intestine].
    Mothes T; Neubert R; Fürst W
    Pharmazie; 1983 Jan; 38(1):46-7. PubMed ID: 6844381
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug permeation through synthetic lipid membranes. Part 10: The effects of diffusion layers on the permeation process (author's transl)].
    Fürst W; Neubert R; Reppel L
    Pharmazie; 1980 Feb; 35(2):106-9. PubMed ID: 7384178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protonophoretic activity of hypoglycemic sulfonylureas in black lipid membranes.
    Deleers M; Brasseur R
    Pharmacol Res Commun; 1986 Feb; 18(2):129-36. PubMed ID: 3010341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug permeation through membranes. I. Effect of various substances on amobarbital permeation through polydimethylsiloxane.
    Lovering EG; Black DB
    J Pharm Sci; 1973 Apr; 62(4):602-6. PubMed ID: 4698980
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blockaders of ion channels formed in a lipid bilayer by polyene antibiotics].
    Borisova MP; Ermishkin LN; Zil'bershteĭn AIa
    Biofizika; 1978; 23(6):1093-4. PubMed ID: 719026
    [No Abstract]   [Full Text] [Related]  

  • 17. An in vitro collodion-lipid membrane model for drug absorption studies.
    Brandys J; Kwiek J; Witek J
    Pol J Pharmacol Pharm; 1974; 26(5):519-26. PubMed ID: 4427813
    [No Abstract]   [Full Text] [Related]  

  • 18. Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes.
    Mason RP; Rhodes DG; Herbette LG
    J Med Chem; 1991 Mar; 34(3):869-77. PubMed ID: 2002467
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of lipophilic counter-ions on membrane diffusion of benzydamine.
    Sarveiya V; Templeton JF; Benson HA
    Eur J Pharm Sci; 2005 Sep; 26(1):39-46. PubMed ID: 15950443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of transcorneal permeation of pilocarpine.
    Mitra AK; Mikkelson TJ
    J Pharm Sci; 1988 Sep; 77(9):771-5. PubMed ID: 3225772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.